Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 19, Issue 1
Randomised controlled trial: extended-duration dabigatran is non-inferior to warfarin and more effective than placebo for symptomatic VTE
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Aetiology
Commentary
Randomised controlled trial: extended-duration dabigatran is non-inferior to warfarin and more effective than placebo for symptomatic VTE
Online download statistics by month:
Online download statistics by month: June 2013 to March 2024
Abstract
Full
Pdf
Jun 2013
164
17
16
Jul 2013
46
8
7
Aug 2013
39
1
4
Sep 2013
42
3
2
Oct 2013
24
0
5
Nov 2013
37
2
5
Dec 2013
25
3
3
Jan 2014
106
11
10
Feb 2014
115
8
8
Mar 2014
67
11
18
Apr 2014
40
4
5
May 2014
20
4
6
Jun 2014
19
3
4
Jul 2014
20
1
3
Aug 2014
16
2
2
Sep 2014
27
4
3
Oct 2014
26
10
8
Nov 2014
18
1
2
Dec 2014
14
2
2
Jan 2015
28
3
2
Feb 2015
9
19
16
Mar 2015
21
20
11
Apr 2015
18
9
5
May 2015
21
16
7
Jun 2015
34
8
4
Jul 2015
15
6
3
Aug 2015
21
12
3
Sep 2015
24
10
4
Oct 2015
8
5
0
Nov 2015
20
8
4
Dec 2015
39
18
1
Jan 2016
40
12
4
Feb 2016
23
0
0
Mar 2016
4
0
0
Apr 2016
4
2
1
May 2016
22
0
5
Jun 2016
6
1
4
Jul 2016
11
2
1
Aug 2016
14
0
0
Sep 2016
14
2
0
Oct 2016
15
3
1
Nov 2016
12
2
0
Dec 2016
12
0
0
Jan 2017
17
0
1
Feb 2017
8
0
0
Mar 2017
16
6
3
Apr 2017
37
1
1
May 2017
27
3
2
Jun 2017
23
2
0
Jul 2017
16
2
1
Aug 2017
23
0
0
Sep 2017
37
0
0
Oct 2017
43
2
2
Nov 2017
46
0
0
Dec 2017
27
0
0
Jan 2018
47
4
3
Feb 2018
24
2
1
Mar 2018
44
5
2
Apr 2018
40
1
0
May 2018
32
0
0
Jun 2018
65
0
0
Jul 2018
54
1
0
Aug 2018
39
1
1
Sep 2018
28
0
0
Oct 2018
37
0
0
Nov 2018
70
0
0
Dec 2018
47
0
0
Jan 2019
39
0
0
Feb 2019
60
3
0
Mar 2019
36
2
3
Apr 2019
16
1
0
May 2019
12
0
0
Jun 2019
13
1
0
Jul 2019
21
1
0
Aug 2019
19
0
0
Sep 2019
15
1
3
Oct 2019
33
4
0
Nov 2019
5
0
0
Dec 2019
23
1
1
Jan 2020
12
2
3
Feb 2020
20
0
0
Mar 2020
5
3
0
Apr 2020
17
1
0
May 2020
13
0
0
Jun 2020
13
1
3
Jul 2020
15
1
0
Aug 2020
10
0
1
Sep 2020
31
0
0
Oct 2020
24
0
0
Nov 2020
8
0
0
Dec 2020
14
0
0
Jan 2021
12
0
0
Feb 2021
10
0
3
Mar 2021
17
1
1
Apr 2021
2
0
0
May 2021
2
0
0
Aug 2021
1
0
0
Sep 2021
1
0
0
Oct 2021
9
0
0
Nov 2021
35
0
0
Dec 2021
18
0
0
Jan 2022
25
2
0
Feb 2022
34
0
0
Mar 2022
20
0
0
Apr 2022
19
1
0
May 2022
49
1
0
Jun 2022
37
1
0
Jul 2022
28
0
0
Aug 2022
53
3
0
Sep 2022
43
0
0
Oct 2022
42
0
0
Nov 2022
23
0
0
Dec 2022
14
0
0
Jan 2023
14
0
0
Feb 2023
16
0
0
Mar 2023
8
0
0
Apr 2023
9
3
1
May 2023
20
0
0
Jun 2023
8
0
0
Jul 2023
16
0
0
Aug 2023
10
1
0
Sep 2023
4
0
0
Oct 2023
12
0
0
Nov 2023
25
0
0
Dec 2023
15
1
0
Jan 2024
7
0
0
Feb 2024
18
1
0
Mar 2024
31
1
2
Total
3328
321
227
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF